Cargando…
High Uric Acid Levels in Acute Myocardial Infarction Provide Better Long-Term Prognosis Predictive Power When Combined with Traditional Risk Factors
The current study aimed to investigate the association between serum UA levels and the mortality rate of AMI patients. We analyzed 5888 patients with successfully revascularized AMI (mean age: 64.0 ± 12.7 years). The subjects were divided into the high UA group (uric acid >6.5 mg/dL for males, &g...
Autores principales: | Kim, Soohyun, Hwang, Byung-Hee, Lee, Kwan Yong, Kim, Chan Jun, Choo, Eun-Ho, Lim, Sungmin, Kim, Jin-Jin, Choi, Ik Jun, Park, Mahn-Won, Oh, Gyu Chul, Yoo, Ki Dong, Chung, Wook Sung, Ahn, Youngkeun, Jeong, Myung Ho, Chang, Kiyuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573253/ https://www.ncbi.nlm.nih.gov/pubmed/36233397 http://dx.doi.org/10.3390/jcm11195531 |
Ejemplares similares
-
Independent Clinical Impacts of Procedural Complexity on Ischemic and Bleeding Events in Patients with Acute Myocardial Infarction: Long-Term Clinical Study
por: Lee, Kwan Yong, et al.
Publicado: (2022) -
Clinical benefit of long-term use of dual antiplatelet therapy for acute myocardial infarction patients with the PEGASUS-TIMI 54 criteria
por: Lee, Kwan Yong, et al.
Publicado: (2022) -
Triple Antiplatelet Therapy with Cilostazol and Favorable Early Clinical Outcomes after Acute Myocardial Infarction Compared to Dual Antiplatelet Therapy with Standard or Potent P2Y12 Inhibitors
por: Byun, Sungwook, et al.
Publicado: (2022) -
Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Lim, Sungmin, et al.
Publicado: (2019) -
Prognostic Impact of the HFA-PEFF Score in Patients with Acute Myocardial Infarction and an Intermediate to High HFA-PEFF Score
por: Lee, Kwan Yong, et al.
Publicado: (2022)